Maravai LifeSciences Holdings, Inc. - Class A common stock — Quarterly Financial Statistics (NASDAQ:MRVI) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -9.39 M-10.27 M-15.15 M-22.77 M8.66 M3.99 M -25.26 M Cash from investing activities -23.13 M-3.24 M-2.93 M-2.11 M-4.44 M-370 K -9.85 M Cash from financing activities -4.9 M-1.53 M-8.25 M-1.82 M-55.23 M-98.98 M -164.27 M Free cash flow -9.39 M-10.27 M-18.08 M-24.88 M4.23 M3.62 M -35.11 M

News

Maravai LifeSciences: The Post-COVID Reset Has Created An RNA Consumables Flywheel (MRVI)

Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2026 Earnings Call Transcript

Maravai LifeSciences Holdings, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:MRVI) 2026-08-06

Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q2 Loss, Beats Revenue Estimates

The Disinflation Trade Has A New Address: Genomics

Maravai LifeSciences: Better Earnings Drive Gains That Ought To Be Sustainable (MRVI)

Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2026 Earnings Call Transcript

Maravai LifeSciences Holdings, Inc. (MRVI) Tops Q1 Earnings and Revenue Estimates

All You Need to Know About Maravai LifeSciences (MRVI) Rating Upgrade to Buy

Baxter International (BAX) Tops Q1 Earnings and Revenue Estimates

Maravai LifeSciences Holdings, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:MRVI) 2026-02-26

Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q4 Loss, Beats Revenue Estimates